Richard S. Levy

Insider Reports History

Entity
Individual
Location
860 Washington Street, 3 Rd Floor, New York, NY
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard S. Levy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MADRIGAL PHARMACEUTICALS, INC. Director Common Stock 11K $3.85M $350.00 Nov 7, 2024 Direct
Kiniksa Pharmaceuticals International, plc Director Class A Ordinary Share 14.2K $327K $23.00 Nov 7, 2024 Direct
Kiniksa Pharmaceuticals, Ltd. Director Class A Common Share 12.9K $231K $17.88 Jun 6, 2024 Direct
Kodiak Sciences Inc. Director Stock Option (Right to Buy) 40K Jun 28, 2024 Direct
Kiniksa Pharmaceuticals, Ltd. Director Share Option 19K Jun 5, 2024 Direct
Protara Therapeutics, Inc. Director Stock Option (Right to Buy) 10K Jun 7, 2024 Direct
MADRIGAL PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 5K Nov 7, 2024 Direct
CONSTELLATION PHARMACEUTICALS INC Director Stock Option (right to buy) 0 Jul 15, 2021 Direct
Kiniksa Pharmaceuticals International, plc Director Restricted Share Units 0 Nov 7, 2024 Direct
Kiniksa Pharmaceuticals, Ltd. Director Restricted Share Units 0 Jun 6, 2024 Direct

Insider Reports Filed by Richard S. Levy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KNSA Kiniksa Pharmaceuticals International, plc Nov 7, 2024 3 $0 4 Nov 12, 2024 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Nov 7, 2024 3 -$1.71M 4 Nov 8, 2024 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Nov 1, 2024 6 -$1.47M 4 Nov 5, 2024 Director
KOD Kodiak Sciences Inc. Jun 28, 2024 1 $0 4 Jul 1, 2024 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jun 25, 2024 2 $0 4 Jun 27, 2024 Director
TARA Protara Therapeutics, Inc. Jun 7, 2024 1 $0 4 Jun 10, 2024 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 5, 2024 4 $0 4 Jun 7, 2024 Director
KNSA Kiniksa Pharmaceuticals, Ltd. May 3, 2024 3 $0 4 May 7, 2024 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Apr 1, 2024 10 -$2.13M 4 Apr 3, 2024 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Nov 3, 2023 3 $0 4 Nov 7, 2023 Director
KOD Kodiak Sciences Inc. Jun 30, 2023 1 $0 4 Jul 3, 2023 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2023 2 $0 4 Jul 3, 2023 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
TARA Protara Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 6, 2023 2 $0 4 Jun 8, 2023 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 17, 2023 14 -$4.28M 4 Jan 19, 2023 Director
KOD Kodiak Sciences Inc. Jun 30, 2022 1 $0 4 Jul 5, 2022 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2022 2 $0 4 Jun 30, 2022 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jun 16, 2022 1 $0 4 Jun 21, 2022 Director
TARA Protara Therapeutics, Inc. Jun 8, 2022 1 $0 4 Jun 9, 2022 Director
CNST CONSTELLATION PHARMACEUTICALS INC Jul 15, 2021 2 $0 4 Jul 19, 2021 Director
KOD Kodiak Sciences Inc. Jun 30, 2021 1 $0 4 Jul 2, 2021 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2021 1 $0 4 Jun 30, 2021 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director
TARA Protara Therapeutics, Inc. Jun 9, 2021 1 $0 4 Jun 10, 2021 Director
CNST CONSTELLATION PHARMACEUTICALS INC Jun 2, 2021 1 $0 4 Jun 4, 2021 Director